Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Merck & Co. Inc. Add to portfolio

INX:MRK, Jul 16, 09:41 UTC

Latest INX:MRK News

Filter your feed

Apply Filter

Sunday, July 01


Social Chatter

Merck & Co. Inc. (INX:MRK) social chatter is higher than usual

MRK
Another reason to Impeach 45: He is unable to process simple facts & believes only what he wants to hear. Mental co… https://t.co/gzpAzbwemi

Sunday, June 17


News

D-E Shaw & Company INC Has Raised Its Merck & Co INC (MRK) Stake by $873.24 Million; Share Price Rose

MRK MRK

Hemenway Limited Liability has 0.54% invested in Merck & Co., Inc. (NYSE:MRK) for 52,044 shares. The hedge fund run by David Shaw held 16.43 million shares of the health care company at the end of 2018Q1, valued at $895.14 million, up from 262,500 at the end of the previous reported quarter. D-E Shaw & Company Inc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $166.88B market cap company. D-E Shaw & Company Inc, which manages about $81.36B and $73.46B US Long portfolio, decreased its stake in Eog Res Inc (Put) (NYSE:EOG) by 82,100 shares to 23,200 shares, valued at $2.44M in 2018Q1, according to the filing.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, June 06


News

Drexel Morgan & Company Has Lowered Its Position in Merck & Co (MRK) as Share Value Rose; As Csx (CSX) Stock Price Rose, Valinor Management Lifted Stake

MRK RDSB +3 more MRK RDSB RDSA CSX XOM

Drexel Morgan & Company Has Lowered Its Position in Merck & Co (MRK) as Share Value Rose; As Csx (CSX) Stock Price Rose, Valinor Management Lifted Stake. The hedge fund run by David Gallo held 1.85M shares of the railroads company at the end of 2018Q1, valued at $103.24 million, up from 652,000 at the end of the previous reported quarter. EXPAND MRNA CANCER VACCINES PACT; 16/04/2018 – BRISTOL-MYERS SQUIBB CO – SAFETY PROFILE FOR OPDIVO AT TWO-YEAR FOLLOW-UP WAS CONSISTENT WITH PREVIOUS ANALYSES FROM STUDY; 08/05/2018 – Merck & Co at Deutsche Bank Health Care Conference Tomorrow; 08/03/2018 – MERCK KGAA MRCG.DE CEO SAYS ARE PLEASED WITH INTEREST BY PROSPECTIVE BUYERS/PARTNERS; 03/04/2018 – EMA ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA® (OLAPARIB) IN; 13/04/2018 – Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy in a Predominantly; 08/03/2018 – TOKYO — Eisai said Thursday it has agreed to collaborate with U.S. counterpart Merck on development and marketing of the Japanese pharmaceutical company’s cancer drug Lenvima, a deal that also brings a timely infusion of cash; 27/03/2018 – Uptake of Merck KGaA’s Mavenclad in the European Multiple Sclerosis Market Currently Stalled Due to Restrictive Guidelines and Pending Additional Country-Level Approvals; 16/04/2018 – DYNAVAX INTERIM DATA FOR SD-101 IN COMBINATION WITH KEYTRUDA® (; 23/05/2018 – THREE DEMOCRATIC REPUBLIC OF CONGO EBOLA PATIENTS ESCAPED QUARANTINE IN CITY OF MBANDAKA – MSF. Since May 2, 2018, it had 1 buying transaction, and 0 insider sales for $299,550 activity. It turned negative, as 79 investors sold CSX shares while 328 reduced holdings.

Read Full Details

Topics:
  • Business
  • Financial
News

Csx (CSX) Holder Par Capital Management Has Decreased Stake as Market Value Rose; Moors & Cabot Lifted Position in Key Tronic (KTCC) as Stock Value Rose

MRK CSX

Drexel Morgan & Company Has Lowered Its Position in Merck & Co (MRK) as Share Value Rose; As Csx (CSX) Stock Price Rose, Valinor Management Lifted Stake. The hedge fund run by David Gallo held 1.85M shares of the railroads company at the end of 2018Q1, valued at $103.24 million, up from 652,000 at the end of the previous reported quarter. EXPAND MRNA CANCER VACCINES PACT; 16/04/2018 – BRISTOL-MYERS SQUIBB CO – SAFETY PROFILE FOR OPDIVO AT TWO-YEAR FOLLOW-UP WAS CONSISTENT WITH PREVIOUS ANALYSES FROM STUDY; 08/05/2018 – Merck & Co at Deutsche Bank Health Care Conference Tomorrow; 08/03/2018 – MERCK KGAA MRCG.DE CEO SAYS ARE PLEASED WITH INTEREST BY PROSPECTIVE BUYERS/PARTNERS; 03/04/2018 – EMA ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA® (OLAPARIB) IN; 13/04/2018 – Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy in a Predominantly; 08/03/2018 – TOKYO — Eisai said Thursday it has agreed to collaborate with U.S. counterpart Merck on development and marketing of the Japanese pharmaceutical company’s cancer drug Lenvima, a deal that also brings a timely infusion of cash; 27/03/2018 – Uptake of Merck KGaA’s Mavenclad in the European Multiple Sclerosis Market Currently Stalled Due to Restrictive Guidelines and Pending Additional Country-Level Approvals; 16/04/2018 – DYNAVAX INTERIM DATA FOR SD-101 IN COMBINATION WITH KEYTRUDA® (; 23/05/2018 – THREE DEMOCRATIC REPUBLIC OF CONGO EBOLA PATIENTS ESCAPED QUARANTINE IN CITY OF MBANDAKA – MSF. Since May 2, 2018, it had 1 buying transaction, and 0 insider sales for $299,550 activity. It turned negative, as 79 investors sold CSX shares while 328 reduced holdings.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, June 03


Social Chatter

Merck & Co. Inc. (INX:MRK) social chatter is higher than usual

MRK
#ASCO18 $MRK KEYNOTE-407 data for Keytruda + chemo combo in 1L squamous NSCLC https://t.co/Jtpj3Z1SZG Much better… https://t.co/2XvWxZImyY

Saturday, June 02


News

Merck & Co INC (MRK) Holder State Board Of Administration Of Florida Retirement System Has Cut Stake by $4.43 Million as Share Price Rose

MRK MRK

The institutional investor held 3.78M shares of the health care company at the end of 2018Q1, valued at $206.08 million, down from 3.87M at the end of the previous reported quarter. State Board Of Administration Of Florida Retirement System, which manages about $36.46B US Long portfolio, upped its stake in Ishares Tr (IWM) by 263,800 shares to 519,699 shares, valued at $78.91M in 2018Q1, according to the filing. More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Livetradingnews.com which released: “Merck & Co., Inc. (NYSE:MRK) Trending Upwards” on May 18, 2018, also Seekingalpha.com with their article: “Merck: Getting Stronger” published on May 04, 2018, Seekingalpha.com published: “Neon Therapeutics readies IPO” on June 01, 2018. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Friday, March 23 with “Hold” rating. As per Friday, April 20, the company rating was maintained by Cowen & Co. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Friday, April 13 with “Hold” rating.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, May 30


News

Bristol Myers Squibb Co (BMY) Stock Value Declined While Sessa Capital Im LP Lowered Its Position; Marcus & Millichap Com (MMI) Share Value Rose While Reinhart Partners Has Trimmed Its Stake

MRK BMY

The institutional investor held 175,000 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $11.07 million, down from 4.53M at the end of the previous reported quarter. The stock increased 1.59% or $0.83 during the last trading session, reaching $53.1. More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers Squibb (BMY) Presents at UBS Global Healthcare Conference (Transcript)” on May 22, 2018, also Fool.com with their article: “Why Bristol-Myers Squibb Stock Crashed in April” published on May 09, 2018, Bizjournals.com published: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” on May 01, 2018. Ckw Fin Gru reported 1,500 shares stake. Since December 12, 2017, it had 2 buys, and 1 insider sale for $163,963 activity.

Read Full Details

Topics:
  • Business
  • Financial
News

As Mckesson (MCK) Market Value Declined, Holder Sva Plumb Wealth Management Has Lifted Its Position; As Merck & Co New Com (MRK) Share Price Rose, Blackhill Capital Has Increased Its Position

MRK DGE +1 more MRK DGE MCK

The hedge fund run by John A. Levin held 6,000 shares of the beverages (production and distribution) company at the end of 2018Q1, valued at $203,000, down from 126,206 at the end of the previous reported quarter. Levin Capital Strategies Lp who had been investing in Diageo P L C for a number of months, seems to be less bullish one the $89.98B market cap company. Levin Capital Strategies Lp, which manages about $8.28B and $5.50B US Long portfolio, upped its stake in Dish Network Corp (NASDAQ:DISH) by 280,640 shares to 288,334 shares, valued at $10.93 million in 2018Q1, according to the filing. By1 Peter Erickson. As Merck & Co (MRK) Share Price Rose, Btc Capital Management Has Boosted Its Position by $364,932; Diageo P L C (DEO) Holder Levin Capital Strategies LP Has Trimmed Its Position by $3.97 Million as Share Value Rose.

Read Full Details

Topics:
  • Business
  • Financial

Monday, May 28


News

Huber Capital Management LLC Lifted Merck & Co INC (MRK) Holding by $3.43 Million

MRK MRK

Neumann Capital Mngmt Limited Liability Com holds 0.18% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 5,332 shares. The hedge fund run by Joe Huber held 493,256 shares of the health care company at the end of 2017Q4, valued at $27.76 million, up from 431,956 at the end of the previous reported quarter. Huber Capital Management Llc, which manages about $3.94 billion and $1.84 billion US Long portfolio, decreased its stake in Harsco Corp (NYSE:HSC) by 420,009 shares to 1.03M shares, valued at $19.29M in 2017Q4, according to the filing. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: 247Wallst.com and their article: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” published on April 30, 2018 as well as Benzinga.com‘s news article titled: “Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning” with publication date: April 30, 2018.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, May 27


News

As Merck & Co INC (MRK) Stock Value Declined, Wellington Management Group Llp Has Decreased Position by $645.22 Million

MRK MRK

The institutional investor held 94.11M shares of the health care company at the end of 2017Q4, valued at $5.30B, down from 105.63 million at the end of the previous reported quarter. Wellington Management Group Llp, which manages about $452.59 billion US Long portfolio, upped its stake in Skechers U S A Inc (NYSE:SKX) by 1.96M shares to 2.25M shares, valued at $84.96 million in 2017Q4, according to the filing. It also increased its holding in Select Sector Spdr Tr (XLF) by 659,862 shares in the quarter, for a total of 697,407 shares, and has risen its stake in Envision Healthcare Corp. Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on July, 27. More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Streetinsider.com which released: “Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)” on May 24, 2018, also Seekingalpha.com with their article: “New Ebola outbreak hits Congo” published on May 13, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018.

Read Full Details

Topics:
  • Business
  • Financial